TREATMENT OF SEVERE COMMUNITY-ACQUIRED PNEUMONIA BY ADMINISTRATION OF TISSUE FACTOR PATHWAY INHIBITOR(TFPI) - Patent 1871408

(19)

(11)

EP 1 871 408 A2

(12)

(88)	Date of publication A3:
	12.04.2007

(43)	Date of publication:
	02.01.2008 Bulletin 2008/01

(21)	Application number: 06750055.3

(22)	Date of filing: 14.04.2006

(51)

International Patent Classification (IPC):

A61K 38/57^(2006.01)

(86)	International application number:
	PCT/US2006/013890

(87)	International publication number:
	WO 2006/113360 (26.10.2006 Gazette 2006/43)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
	Designated Extension States:
	HR

(30)

Priority:

15.04.2005 US 671466 P

(71)	Applicants:
	Novartis Vaccines and Diagnostics, Inc. Emeryville, CA 94608 (US) Creasey, Abla Emeryville CA 94662-8097 (US)

(72)	Inventor:
	Creasey, Abla Emeryville, CA 94662-8097 (US)

(74)	Representative: Marshall, Cameron John et al
	Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA London WC1A 2RA (GB)

(54)	TREATMENT OF SEVERE COMMUNITY-ACQUIRED PNEUMONIA BY ADMINISTRATION OF TISSUE FACTOR PATHWAY INHIBITOR(TFPI)